It has been suggested that cholecystokinin, a neurotransmitter found in high density in mammalian brain, might be implicated in the neurobiology of panic and anxiety disorders. Cholecystokinin-tetrapeptide induces panic attacks analogous to spontaneous panic attacks in patients suffering from panic disorder and to a much lesser degree in healthy volunteers, suggesting an enhanced sensitivity to cholecystokinin-tetrapeptide in panic disorder. In animal models of anxiety, pre-treatment with cholecystokinin antagonists significantly decreases the anxiogenic effects of cholecystokinin agonists. This paper reviews clinical and basic studies supporting an involvement for cholecystokinin in panic and anxiety disorders.
Abelson J.L., Nesse R.M. (1990) Cholecystokinin-4 and panic. Arch Gen Psychiatr47: 395
2.
Beinfeld M.C. (1983) Cholecystokinin in the central nervous system: A mini-review. Neuropeptide3: 411-427
3.
Bolles R.C., Fansellow M.S. (1980) A perceptual-defensive-recuperative model of fear and pain. Behav Brain Sci3: 291-302
4.
Bouthillier A., de Montigny C. (1988) Long term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: An electrophysiological study in the rat . Eur J Pharmacol151: 135-138
5.
Bradwejn J., de Montigny C. (1984) Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurons. Nature312: 363-364
6.
Bradwejn J., de Montigny C. (1985a) Effects of PK 8165, a partial benzodiazepine receptor agonist, on cholecystokinin-induced activation of hippocampal pyramidal neurons: A microiontophoretic study in the rat. Eur J Pharmacol112: 415-418
7.
Bradwejn J., de Montigny C. (1985b) Antagonism of cholecystokinin-induced activation by benzodiazepine receptor agonists. Ann N Y Acad Sci448: 575-580
8.
Bradwejn J., Koszycki D. (1991a) CCK-4 and panic attacks in man. Oxford University Press (in press)
9.
Bradwejn J., Koszycki D. (1991b) Comparison of CO2-induced panic attacks with cholecystokinin-induced panic attacks in panic disorder. Prog Neuro-Psychopharmacol Biol Psychiatr15: 237-239
10.
Bradwejn J., Koszycki D., Meterissian G. (1990) Cholecystokinin-tetrapeptide induced panic attacks in patients with panic disorder. Can J Psychiatr35: 83-85
11.
Bradwejn J., Koszycki D., Bourin M. (1991a) Dose ranging study of the effect of CCK-4 in healthy volunteers. J Psychiatr Neurosci16: 260-264
12.
Bradwejn J., Koszycki D., Payeur R. (1991b) Cholecystokinin-tetrapeptide : A provocation agent for research in panic disorders? In Briley M, File S (eds), New concepts in anxiety. MacMillan Press, London, pp. 313-319
13.
Bradwejn J., Koszycki D., Payeur R., Borthwick H. (1991c) Replication of action of cholecystokinin-tetrapeptide in panic disordered patients. New Research Program and Abstracts, 144th Meeting of the American Psychiatric Association, New Orleans, May 14, NR 367 p. 136
14.
Bradwejn J., Koszycki D., Shriqui C. (1991d) Enhanced sensitivity to cholecystokinin-tetrapeptide in panic disorder: Clinical and behavioural findings. Arch Gen Psychiatr48: 603-607
15.
Bradwejn J., Koszycki D., Cöuetoux du Tertre A., van Megen H., den Boer J., Wertenberg H., Karkanias C., Haigh J. (1992) L-365, 260, A CCKB antagonist, blocks CCK-4-panic. New Research Program and Abstracts, 145th Meeting of the American Psychiatric Association, Washington DC, May 6, NR 475 p. 164
16.
Collins S., Walker D., Forsyth P., Belbeck L. (1983) The effects of proglumide on cholecystokinin-, bombesin-, and glucagon-induced satiety in the rat. Life Sci32: 2223-2229
17.
Csonka E., Fekete M., Nagy G., Szanto-Fekete M., Feledgy G., Penke B., Kovaks K. (1988) Anxiogenic effect of cholecystokinin in rats. In Penke B, Torok A (eds), Peptides. Walter de Gruyter & Co., New York, pp. 249-252
18.
de Montigny C. (1989) Cholecystokinin-tetrapeptide induces panic-like attacks in healthy volunteers. Arch Gen Psychiatr46: 511-517
19.
Degli Uberti E.C., Trasforini G., Margutti A.R., Rotola C.A., Pansini R. (1983) Effects of pentagastrin on adrenocorticotropin hormone and thyroid stimulating hormone release in normal subjects. Hormone Res17: 74-77
20.
Deupree D., Hsiao S. (1987) Cholecystokinin octapeptide, proglumide, and conditioned taste avoidance in rats. Physiol Behav41: 125-128
21.
Dodd J., Kelly J.S. (1979) Excitation of CA1 pyramidal neurons of hippocampus by the tetra- and octapeptide C-terminal fragment of cholecystokinin. J Physiol (295: 61P-62P
22.
Dodd P.R., Edwarson J.A., Dockray G.J. (1980) The depolarization-induced release of cholecystokinin C-terminal octapeptide (CCK-8) from rat synaptosomes and brain slices. Regul Peptides1: 17-29
23.
Dourish C.T., Hill D.R. (1987) Classification and function of CCK receptors. Trends Pharmacol Sci8: 207-208
24.
Emson P.C., Lee C.M., Rehfeld J.F. (1980) Cholecystokinin peptides: Vesicular localization and calcium dependent release from rat brain in vitro. Life Sci26: 2157-2162
25.
Ervin F., Palmour R., Bradwejn J. (1991) A new primate model for panic disorder. New Research Program and Abstracts, 144th Meeting of the American Psychiatric Association, New Orleans, May 14, NR 216 p. 100
26.
File S. ( 1990) Testing new antianxiety agents: Pharmacology and biochemistry . In Burrows G D, Roth M, Noyes R (eds) Handbook of anxiety, vol. 3: the neurobiology of anxiety. Elsevier Science Publishers, B. V. Amsterdam, pp. 141-162
27.
Freidinger R.M. (1989) Cholecystokinin and gastrin antagonists. Med Res Rev9: 271-290
28.
Friedman S., Sunderland G.S., Rosenblaum L.A. (1987) A non-human model of panic disorder. Psychiatr Res23: 65-75
29.
Goltermann N.R., Rehfeld J.F., Roigaard-Petersen H. (1980) In vivo biosynthesis of cholecystokinin in rat cerebral cortex. J Biol Chem255: 6181-6185
30.
Gorman J.M., Fyer M.R., Liebowitz M.R., Klein D.F. (1987) Pharmacologic provocation of panic attacks. In Meltzer H Y (ed.), Psychopharmacology: a third generation of progress. Raven Press, New York, pp. 980-983
31.
Guttmacher L.B., Murphy D.L., Insel T.R. (1983) Pharmacologic models of anxiety. Comp Psychiatr24: 312-326
32.
Haefely W.E. (1990) The GABAA-benzodiazepine receptors: Biology and pharmacology. In Burrows G D, Roth M, Noyes R (eds), The neurobiology of anxiety. Elsevier, New York, pp. 165-188
33.
Harro J., Vasar E. (1991) Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat. Eur J Pharmacol193: 379-381
34.
Harro J., Kiivet R.A., Lang A., Vasar E. (1990a) Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics . Behav Brain Res39: 63-71
35.
Harro J., Pold M., Vasar E. (1990b) Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: Influence of acute and subchronic diazepam treatment . Naunyn-Schmiedeberg's Arch Pharmacol341: 62-67
36.
Hays S.E., Beinfeld M.C., Jensen R.T., Goodwin F.K., Paul S.M. (1980) Demonstration of a putative receptor site for cholecystokinin in rat brain. Neuropeptides1: 53-62
37.
Hill D.R., Campbell N.J., Shaw T.M., Woodruff G.N. (1987) Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective non-peptide CCK agonists. J Neurosci7: 2967-2976
38.
Hughes J., Boden P., Costall B., Domeney A., Kelly E., Horwell D.C., Hunter J.C., Pinnock R.D., Woodruff G.N. (1990) Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA87: 6728-6732
39.
Innis R.B., Correa F M A, Uhl G.R., Schneider B., Snyder S.H. (1979) Cholecystokinin octapeptide-like immunoreactivity: Histochemical localization in rat brain. Proc Natl Acad Sci USA76: 521-525
40.
Koszycki D., Bradwejn J., Bourin M. (1991) Comparison of the effects of cholecystokinin and carbon dioxide in healthy volunteers. Eur Neuropharmacol1: 137-141
41.
Kubota K., Sugaya K., Sunagane N., Matsuoka Y., Uruno T. (1985a) Cholecystokinin antagonism by benzodiazepines in the contractile response of the isolated guinea-pig gallbladder. Eur J Pharmacol110: 225-231
42.
Kubota K., Sugaya K., Matsuda I., Matsuoka Y., Terawaki Y. (1985b) Reversal of antinociceptive effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist. Jap J Pharmacol37: 101-105
43.
Larsson L.E., Rehfeld J.F. (1979) Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res165: 201-218
44.
Lydiard R.B., Ballenger J.C., Laraia M.T., Fossey M.D., Beinfeld M.C. (1992) CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. Am J Psychiatr149: 691-693
45.
Margraf J., Ehlers A., Roth W.T. (1986) Sodium lactate infusions and panic attacks: A review and critique. Psychosom Med48: 23-51
46.
Martinez J., Rodriguez M., Lignon M.F. (1988) Cholecystokinin receptor antagonist. In Wang R Y, Schoenfeld R (eds), Cholecystokinin antagonists. Alan Liss Inc. , New York, pp. 29-51
47.
Morley P.D., Rehfeld J.F., Emson P.C. (1984) Distribution and chromatographic characterization of gastrin and cholecystokinin in the rat central nervous system. J Neurochem42: 1523-1535
48.
Moran T.H., Robinson PH, Goldrich M.S., McHugh P.R. (1986) Two brain cholecystokinin receptors: Implications for behavioral actions. Brain Res362: 175-179
49.
Nair N P V, Bloom D., Lal S., Debonnel G., Schwartz G., Mosticyan S. (1985) Clinical and neuroendocrine studies with cholecystokinin peptides. Ann N Y Acad Sci448: 535-541
50.
Norman T.R., Judd F.K., Burrows G.D. (1990) Catecholamine and anxiety. In Burrows G D, Roth M, Noyes R (eds), The neurobiology of anxiety . Elsevier, New York, pp. 223-241
51.
Nutt D., Glue P., Lawson C. (1990) Flumazenil provocation of panic attacks. Arch Gen Psychiatr47: 917-925
52.
Nutt D.J., George D.T. (1990) Serotonin and anxiety. In Burrows G D, Roth M, Noyes R (eds), The neurobiology of anxiety . Elsevier, New York, pp. 189-222
53.
Palmour R., Ervin R., Bradwejn J., Howbert J. (1991) The anxiogenic and cardiovascular effects of CCK-4 are blocked by the CCK-B antagonist LY262,691. Abstract n. 637.1. Soc Neurosci17: 1602
54.
Passaro E., Bebas H., Oldendorf W., Yamada T. (1982) Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation. Brain Res241: 335-340
55.
Pinget M., Straus E., Yalow R.S. (1978) Localization of cholecystokinin-like immunoreactivity in isolated nerve terminals. Proc Natl Acad Sci USA75: 6324-6326
56.
Pinget M., Straus E., Yalow R.S. (1979) Release of cholecystokinin peptides from a synaptosome-enriched fraction of rat cerebral cortex. Life Sci25: 339-342
57.
Rataud J., Darche F., Piot O., Stutzmann J.M., Bohme G.A., Blanchard J.C. (1991) "Anxiolytic" effect of CCKantagonists on plus-maze behavior in mice. Brain Res548: 315-317
58.
Ravard S., Dourish C. (1990) Cholecystokinin and anxiety. Trends Pharmacol Sci11: 271-273
59.
Rehfeld J.F. (1978) Multiple molecular forms of cholecystokinin. In Bloom, S. R. (ed.), Gut hormones . Churchill Livingstone, Edinburgh , pp. 213-218
60.
Rogawski M.A. (1982) Cholecystokinin octapeptide: Effects on the excitability of cultured spinal neurons. Peptides3: 545-551
61.
Saito A., Sankaran H., Goldfine I.D., Williams J.A. (1980) Cholecystokinin receptors in the brain: Characterization and distribution. Science208: 1155-1156
62.
Sauter A., Frick W. (1983) Determination of cholecystokinin tetrapeptide and cholecystokinin octapeptide sulfate in different rat brain regions by high-pressure liquid chromatography with electrochemical detection. Anal Biochem133: 307-313
63.
Silverman M.A., Greenberg R.E., Bank S. ( 1987) Cholecystokinin receptor antagonists: a review. Am J Gastroenterol82: 703-708
64.
Singh L., Lewis A.S., Field M.J., Hugues J., Woodruff G.N. (1991) Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc Natl Acad Sci USA88: 1130-1133
65.
Skirboll L., Grace A.A., Hommer D.W., Rehfeld J.F., Goldstein M., Hokfelt T., Bunney B.S. (1981) Peptide-monoamine coexistence: Studies on the actions of cholecystokinin-like peptides on the electrical activity of midbrain dopamine neurons. Neuroscience6: 2111-2124
66.
Spath-Schwalbe E., Piroth L., Pietrowsky R., Born J., Lorenz Fehm H. (1988) Stimulation of the pituitary adrenocortical system in man by cerulein, a cholecystokinin-8-like peptide. Clin Physiol Biochem6: 316-320
67.
Vanderhaegen J-J., Lofstra F., Vierendeels G., Gilles C., Deschepper C., Verbauck P. (1981) Cholecystokinin in the central nervous system and neurohypophysis. Peptides2: 81-88
68.
Vandijk A., Richard J.G., Trzeciak A., Gillessen D., Mohler H. (1984) Cholecystokinin receptors: Biochemical demonstration and autoradiographical localization in rat brain and pancreas using [ 3H] cholecystokinin as radioligand. J Neurosci4: 1021-1033
69.
Woodruff G.N., Hugues J. (1991) Cholecystokinin antagonists. Annu Rev Pharmacol Toxicol31: 469-501
